In Press1 Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and N. America 2002-2009. S Abgrall on behalf of the Antiretroviral Therapy Cohort Collaboration (ART-CC).
AIDS. 2012 Nov 28 [Epub ahead of print].2 Short and long term mortality and causes of death in HIV/TB patients in Europe. D N Podlekareva, A M Panteleev, D Grint, F A Post, J M Miro, M Bruyand, H Furrer, N Obel, E Girardi, A Vasilenko, M H Losso, A Arenas-Pinto, J Caylá, A Rakhmanova, I Zeltina, A M Werlinrud, J D Lundgren, A Mocroft, O Kirk and the HIV/TB study group.
European Respiratory Journal. In press
3 Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-related Death in HIV/Viral Hepatitis Coinfected Patients. L Peters, A Mocroft, V Soriano, J Rockstroh, A. Rauch, A Karlsson, B Knysz, C Pradier, K Zilmer, JD Lundgren, for EuroSIDA in EuroCoord.
PLoS One. In Press
4 Insurability of HIV positive people treated with antiretroviral therapy in Europe : Collaborative analysis of HIV cohort studies. J Kaulittz-Bartz J, W Dam, MT May, B Ledergerber, U Widmer, AN Phillips, S Grabar, A Mocroft et al.
AIDS 2013. In Press.
5 Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). MT May, SM Ingle, D Costagliola, AC Justice, F de Wolf, M Cavassini, A D’arminio Monforte, J Casabona, RS Hogg, A Mocroft et al.
Int J Epidemiol 2013. In Press